These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1528061)

  • 21. In vitro response of normal and aplastic anemia bone marrow to mast cell growth factor and in combination with granulocyte-macrophage colony-stimulating factor and interleukin-3.
    Gibson FM; Scopes J; Daly S; Ball SE; Gordon-Smith EC
    Exp Hematol; 1994 Mar; 22(3):302-12. PubMed ID: 8112428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulatory abnormalities in the marrow of patients with myelodysplastic syndromes.
    Merchav S; Nagler A; Fleischer-Kurtz G; Tatarsky I
    Br J Haematol; 1989 Oct; 73(2):158-64. PubMed ID: 2479408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mast cell growth factor (c-kit ligand) restores growth of multipotent progenitors in myelodysplastic syndrome.
    Glinsmann-Gibson B; Spier C; Baier M; Taetle R; Broudy VC; List AF
    Leukemia; 1994 May; 8(5):827-32. PubMed ID: 7514248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blast colony-forming cells in myelodysplastic syndrome: decreased potential to generate erythroid precursors.
    Backx B; Broeders L; Touw I; Löwenberg B
    Leukemia; 1993 Jan; 7(1):75-9. PubMed ID: 8418382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth of human hematopoietic colonies from patients with myelodysplastic syndromes in response to recombinant human granulocyte-macrophage colony-stimulating factor.
    Carlo-Stella C; Cazzola M; Bergamaschi G; Bernasconi P; Dezza L; Invernizzi R; Pedrazzoli P
    Leukemia; 1989 May; 3(5):363-6. PubMed ID: 2654496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. c-kit ligand augments granulocyte-macrophage colony growth from patients with 5q- syndrome.
    Rosenfeld CS; Nemunaitis J; Sherer CR; Zeigler ZR; Shadduck RK
    Stem Cells; 1993 Nov; 11(6):562-7. PubMed ID: 7509225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro growth modulation by L-ascorbic acid of colony-forming cells from bone marrow of patients with myelodysplastic syndromes.
    Park CH; Kimler BF; Bodensteiner D; Lynch SR; Hassanein RS
    Cancer Res; 1992 Aug; 52(16):4458-66. PubMed ID: 1643638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered responses of purified blast cells from the myelodysplastic syndromes to colony-stimulating factors in vitro: comparison with normal blast cells.
    Tohyama K; Ueda T; Yoshida Y; Nakamura T
    Exp Hematol; 1994 Jul; 22(7):539-45. PubMed ID: 7516887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stem cell factor improvement of proliferation and maintenance of hemopoietic progenitors in myelodysplastic syndromes.
    Piacibello W; Sanavio F; Bresso P; Severino A; Carlesso N; Pregno P; Stacchini A; Morelli S; Fubini L; Gallo E
    Leukemia; 1994 Feb; 8(2):250-7. PubMed ID: 7508532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response of myelodysplastic syndrome marrow progenitor cells to stimualtion with cytokine combinations in a stroma-free long-term culture system.
    Soligo DA; Campiglio S; Servida F; Bossolasco P; Romitti L; Cortelezzi A; Lambertenghi Deliliers G
    Br J Haematol; 1996 Mar; 92(3):548-58. PubMed ID: 8616015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural killer (NK) cell activity in human long-term bone marrow cultures (LTBMC): effects of interleukin-2 (IL-2) and granulocyte-macrophage colony-stimulating factor (GM-CSF) on the progenitor cells.
    Sitnicka E; Hansson M
    Immunology; 1992 Jun; 76(2):292-8. PubMed ID: 1634251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myelodysplastic syndrome (MDS)-associated inhibitory activity on haemopoietic progenitor cells.
    Ohmori M; Ohmori S; Ueda Y; Tohyama K; Yoshida Y; Uchino H
    Br J Haematol; 1990 Feb; 74(2):179-84. PubMed ID: 2180470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enrichment of haemopoietic progenitor cells from the marrow of patients with myelodysplasia.
    Baines P; Masters GS; Lush C; Jacobs A
    Br J Haematol; 1988 Feb; 68(2):159-64. PubMed ID: 3280003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heterogeneous colony forming ability in vitro of the abnormal clone-derived granulocyte-macrophage precursors in myelodysplastic syndromes.
    Okuda T; Yokota S; Maekawa T; Sonoda Y; Misawa S; Takino T; Abe T
    Leuk Res; 1988; 12(8):687-92. PubMed ID: 3184986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Haemopoietic growth factor production by normal and aplastic anaemia stroma in long-term bone marrow culture.
    Gibson FM; Scopes J; Daly S; Ball S; Gordon-Smith EC
    Br J Haematol; 1995 Nov; 91(3):551-61. PubMed ID: 8555053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clonal evolutions during long-term cultures of bone marrow from de novo acute myeloid leukaemia with trilineage myelodysplasia and with myelodysplastic remission marrow.
    Tamura S; Kanamaru A; Takemoto Y; Kakishita E; Nagai K
    Br J Haematol; 1993 Jun; 84(2):219-26. PubMed ID: 8398821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of recombinant murine granulocyte-macrophage colony-stimulating factor in cyclophosphamide-treated mice.
    Gamba-Vitalo C; DiGiovanna MP; Sartorelli AC
    Blood Cells; 1991; 17(1):193-205; discussion 206-8. PubMed ID: 2018856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hematopoietic progenitor cells from patients with myelodysplastic syndromes: in vitro colony growth and long-term proliferation.
    Flores-Figueroa E; Gutiérrez-Espindola G; Guerrero-Rivera S; Pizzuto-Chavez J; Mayani H
    Leuk Res; 1999 Apr; 23(4):385-94. PubMed ID: 10229325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peripheral blood granulocyte-macrophage progenitors in patients with the myelodysplastic syndromes.
    Tennant GB; Jacobs A; Bailey-Wood R
    Exp Hematol; 1986 Dec; 14(11):1063-8. PubMed ID: 3780888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human recombinant interferon-inducible protein-10 inhibits the proliferation of normal and acute myelogenous leukemia progenitors.
    Sarris AH; Talpaz M; Deisseroth AB; Estrov Z
    Leukemia; 1996 May; 10(5):757-65. PubMed ID: 8656668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.